FDA Approves Unknown Drug — STRIDES PHARMA INTL

# FDA Approves Generic Drug Application for Strides Pharma International Strides Pharma International received FDA approval for ANDA 040191 on December 17, 1998, marking the company's entry into the generic pharmaceutical market and positioning it to capture market share from branded competitors. The approval strengthens Strides' portfolio in the competitive generic segment, enabling the company to offer cost-effective alternatives to healthcare providers and consumers.